Skip to content

Advertisement

Article collections

Cancer Nanotechnology publishes special collections of articles focusing on a specific topic, guest edited by experts in the field. Each collection serves to illustrate a research area’s present status and/or to highlight cutting-edge developments.

You can view the full list of collections both currently open for submissions and previously published below.

Open for submissions

The following collections are currently open for submissions. New articles are added to collections as they are published.

New Content Item

NEW: Advancing nanoparticles from the bench to the bedside: logistical issues

Edited by Steven Curley, Sunil Krishnan and Željka Krpetić

Interaction with man-made nanoparticles is becoming inescapable in the daily lives of people around the world. This has been enabled by the explosion of research in nanotechnology especially in medicinal and consumer products. This research has catalyzed the design of products with precisely engineered and highly robust functionalities with minimal toxicity. The next step is to advance these exciting new discoveries from the bench to the bedside. Here, there seems to be a bottleneck where very few nanotechnology products have successfully transitioned. Even among those that have moved to clinical testing, many have failed to demonstrate clear clinical benefit. This collection seeks to highlight strategies to overcome potential regulatory, societal, business and legal hurdles.

New Content Item

Nanomaterials to Enhance the Effect of Ionizing Radiation

Edited by Chun Li and Fred Currell

The unique physicochemical properties of nanoparticles have made them especially attractive for mediating enhanced antitumor activity with various energy sources, such as light, magnetic field, radiofrequency, microwave, and ionizing radiation. Enhancement of radioresponse with nanoparticles is attributed to increased drug delivery, synergist interaction with different modes of cell killing, and/or increased cellular exposure to ionizing radiation beams. This collection aims to cover a broad scope of current research on the interaction between nanoparticles and radiation, and provide an outlook for clinical translation of nanotechnology in radiotherapy, one of the pillars of anticancer therapies.

New Content Item

Nanoparticle design and manufacturing in cancer nanotechnology: challenges of drug delivery, targeted treatment and selective detection

Edited by Željka Krpetić

Nanoparticle design is one of the fastest growing fields of applied science. Purposely designing and manufacturing nanoparticles for cancer nanotechnology applications is promising due to the reduced side effects nanoparticles have in diagnostics and treatment of cancer. 
This special collection covers a range of approaches in the field of nanofabrication and/or advanced nanoparticle characterisation that show advancement in design of nano-based tools for drug delivery, targeted treatment and selective detection of cancer.

New Content Item

Pancreatic Cancer

Edited by Steven Curley

Pancreatic ductal adenocarcinoma is one of the most lethal human malignancies. Over ninety-four percent of patients diagnosed with this disease succumb to this cancer. The high density of stromal tissue and aggressive propensity for early metastasis makes this a difficult malignant disease to treat. Nanotechnology holds promise both for increasing the early diagnosis of pancreatic ductal adenocarcinoma and for providing improved therapeutic options. Nanomaterials as vectors to deliver cytotoxic agents, radioisotopes, antibodies, and other targeted therapies holds great promise in improving the outcome of patients diagnosed with pancreatic malignancy. 

Precision Oncology

Cross-journal collection

Due to the heterogeneous nature of tumors, molecular profiling is crucial to our understanding of how genomics plays a role in the cause or development of an individual cancer. Such tumor profiles can subsequently be applied to exclusively tailor cancer therapies to directly target a causative mutation for a malignancy, ultimately achieving a personalized and precise approach to cancer treatment. This approach is termed precision oncology. 
This cross-journal collection of original research and review articles aims to gather the latest research on precision oncology. It will focus on how precision oncology has shaped advances in the impact of non-coding RNAs in epigenetics and cancer, immunotherapy and tumor biology, and the clinical significance of various therapies in a range of cancers. 

New Content Item (1)

Prostate Cancer

Edited by Suneil Jain and Helen McCarthy

Prostate cancer is the most commonly diagnosed cancer in men. Localized disease is commonly treated with androgen deprivation therapy, surgery or radiotherapy but currently many men develop metastatic castrate resistant prostate cancer.
Novel approaches for early diagnosis and improved therapy are required. 
Nanoparticles have enormous potential to act as radiosensitizers, and targeted therapies are being refined for clinical use with the potential to enhance image guided radiotherapy. Furthermore, many nanoparticles have been designed as drug delivery agents with the promise of delivering increased therapeutic payloads directly to the tumor.

Previously published collections

The following collections have previously been published in Cancer Nanotechnology ​​​​​​​and are no longer accepting submissions.

Nano Startup Challenge in Cancer - NSC2
Edited by Fred Currell and Steven Curley
First published: 25 April 2016

Nanoscale Radiation Processes Relevant to Cancer Therapy
Edited by Fred Currell
First published: 1 July 2014

Advertisement